BioCentury
ARTICLE | Financial News

Insero Health debuts with $1.1 million

February 3, 2012 2:13 AM UTC

Insero Health Inc. (Miami, Fla.) raised $1.1 million in a seed round from the Reich Group. Insero is developing huperzine for epilepsy and related diseases. The NMDA receptor antagonist and acetylchol...